Subject area |
Biology |
More specific subject area |
Clinical chemistry, Biomarker analysis, proteoform profiling |
Type of data |
Tables, figures |
How data was acquired |
Ultimate nano-RSLC system (Thermo Fischer Scientific Waltham, USA) coupled to Impact II™ benchtop UHR-Q-ToF (Bruker Daltonik, Bremen, Germany) through a CaptiveSpray nanoBooster™ source (Bruker Datonik, Bremen, Germany)
|
Data format |
Analyzed and processed data |
Experimental factors |
CSF was collected in polypropylene tubes under standardized conditions between 9 a.m. and 1 p.m. in order to minimize the effects of diurnal variations. Each CSF sample was sent within 4 h of being collected to the local laboratory, where it was centrifuged at 1000 × g for 10 min at a temperature of 4 °C. CSF was then aliquoted into 1.5 ml polypropylene tubes and stored at −80 °C.
|
Experimental features |
500 µL of human CSF mixed with twenty-five microliters of 70% perchloric acid, added for protein precipitation. Supernatants were collected and protein clean-up was performed using Oasis HLB µelution well plates. Eluted proteins were dried and resuspended with A phase before LCMS analysis.
|
Data source location |
IRMB, Montpellier hospital, France |
Data accessibility |
Data is with article |